AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPTHEA LTD

0.600

0.000

Volume:- -

Turnover:- -

Market Cap:820.79M

PE:-2.96

High:0.600

Open:0.600

Low:0.600

Close:0.600

52wk High:1.050

52wk Low:0.590

Shares:1.37B

Float Shares:786.04M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.203

EPS(LYR):-0.133

ROE:-3383.08%

ROA:-79.28%

PB:-2.91

PE(LYR):-4.51

Loading ...

Overview Company News Filings

Opthea Begins Development Program To Investigate Potential Lymphangioleiomyomatosis Treatment Candidate

MT Newswires Live

Opthea Limited Issues New Options to Directors Under NED Plan

Opthea Limited unveils strategy to target rare lung disease LAM with OPT-302 relaunch

BNY Mellon Cuts Voting Power in Opthea to 6.37%

Opthea Delisting from Nasdaq Takes Effect

Opthea Limited held its Annual General Meeting

Opthea Ltd: Positioned to Progress and Finalise Its Strategic Review

THOMSON REUTERS

Opthea Continues to Establish Capital Position to Evaluate Strategic Options in the September Quarter

MT Newswires Live

Opthea Ltd: Co Announces Intention to Delist From Nasdaq While Remaining Listed on ASX

THOMSON REUTERS

Opthea Streamlines Global Operations and Focuses on Australian Market

THOMSON REUTERS

Opthea to Voluntarily Delist American Depositary Shares From Nasdaq

MT Newswires Live

Opthea Ltd-Opthea Announces Intention to Delist From Nasdaq

THOMSON REUTERS

Opthea Ltd - Expects to File a Form 25 With U.S. Securities and Exchange Commission (SEC) to Effect Delisting on or About November 10, 2025

THOMSON REUTERS

Opthea Appoints Hamish George as CFO

MT Newswires Live

BRIEF-Opthea Says Hamish George Assumes Role Of CFO

Opthea Ltd-Appointment of Company Secretary and CFO

THOMSON REUTERS

Opthea Limited announces date for annual general meeting

Opthea Ltd: Receives a$10.8 Million R&D Tax Incentive From the Australian Taxation Office - SEC Filing

THOMSON REUTERS

Opthea Limited Secures A$10.8 Million Australian R&D Tax Incentive to Advance Sozinibercept Development

Opthea Limited Reports Decline in Revenue to $25K for Fiscal Year Ending June 30, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OPT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OPT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OPT.AU\",,,,,undefined,":{"symbol":"OPT.AU","market":"AU","secType":"STK","nameCN":"OPTHEA LTD","latestPrice":0.6,"timestamp":1770786720000,"preClose":0.6,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"OPTHEA LTD","floatShares":786037192,"shares":1367978173,"eps":-0.202747,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-11 16:12:00 AEDT","open":0.6,"high":0.6,"low":0.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.202747,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770850800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.6,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OPT.AU\",,,,,undefined,":{"symbol":"OPT.AU","floatShares":786037192,"roa":"-79.28%","roe":"-3383.08%","lyrEps":-0.132923,"shares":1367978173,"dividePrice":0,"high":0.6,"amplitude":0,"preClose":0.6,"low":0.6,"week52Low":0.59,"pbRate":"-2.91","psRate":"4001.64","week52High":1.05,"institutionHeld":0,"latestPrice":0.6,"eps":-0.202747,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.202747,"open":0.6,"prevYearClose":0.6,"prevWeekClose":0.6,"prevMonthClose":0.6,"prevQuarterClose":0.6,"fiveDayClose":0.6,"twentyDayClose":0.6,"sixtyDayClose":0.6,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPT.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OPT.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607065544","title":"Opthea Begins Development Program To Investigate Potential Lymphangioleiomyomatosis Treatment Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2607065544","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607065544?lang=en_us&edition=fundamental","pubTime":"2026-01-30 09:16","pubTimestamp":1769735819,"startTime":"0","endTime":"0","summary":"Opthea (ASX:OPT) said it initiated a development program to investigate its OPT-302 treatment candidate for potentially treating lymphangioleiomyomatosis, starting with evaluating the feasibility of n","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","OPT.AU"],"gpt_icon":0},{"id":"2593453935","title":"Opthea Limited Issues New Options to Directors Under NED Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2593453935","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593453935?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:50","pubTimestamp":1766440238,"startTime":"0","endTime":"0","summary":"Opthea Limited has issued 41,000,000 unquoted options to acquire fully paid ordinary shares to director Ms Katherine Connell. These options, expiring 11 November 2035, were granted under the Non-Executive Directors Share and Option Plan, as approved at the Annual General Meeting on 11 November 2025. No consideration was paid for the options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opthea Limited published the original content used to generate this news brief on December 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL7bB3lC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OPT.AU","BK7067"],"gpt_icon":0},{"id":"2592953786","title":"Opthea Limited unveils strategy to target rare lung disease LAM with OPT-302 relaunch","url":"https://stock-news.laohu8.com/highlight/detail?id=2592953786","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592953786?lang=en_us&edition=fundamental","pubTime":"2025-12-17 07:11","pubTimestamp":1765926674,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opthea Limited published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDLbsgKJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","OPT.AU"],"gpt_icon":0},{"id":"2589611806","title":"BNY Mellon Cuts Voting Power in Opthea to 6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589611806","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589611806?lang=en_us&edition=fundamental","pubTime":"2025-12-08 05:29","pubTimestamp":1765142972,"startTime":"0","endTime":"0","summary":"The Bank of New York Mellon Corporation and its group entities have reported a change in their relevant interest in Opthea Limited, now holding 87,105,313 ordinary shares, representing a voting power of 6.37%. These shares are held as part of Opthea's ADR program, with ADR holders retaining their voting rights.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opthea Limited published the original content used to generate this news brief on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nNDL3qdBgR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU0130517989.USD","BK4135","LU1201861249.SGD","BK7508","BK","BK4585","LU0130102774.USD","LU0648001328.SGD","OPT.AU","LU1699723380.USD","LU0477156953.USD","BK4559","LU1571399168.USD","BK7067","BK4588"],"gpt_icon":0},{"id":"2585574231","title":"Opthea Delisting from Nasdaq Takes Effect","url":"https://stock-news.laohu8.com/highlight/detail?id=2585574231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585574231?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:02","pubTimestamp":1763672570,"startTime":"0","endTime":"0","summary":"Opthea Limited has announced that the voluntary delisting of its American Depositary Shares  from the Nasdaq Global Select Market became effective on November 21, 2025. Following the delisting, Opthea will file a Form 15F to deregister and terminate its reporting obligations in the United States, with deregistration expected to become effective 90 days after the filing. The company's ordinary shares will continue to be listed and primarily traded on the Australian Securities Exchange , although trading remains suspended under ASX Listing Rule 17.3. After leaving Nasdaq, Opthea's ADSs may still be traded through the U.S. Over-The-Counter  market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opthea Limited published the original conten","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDLc8h73y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","OPT.AU"],"gpt_icon":0},{"id":"2582038494","title":"Opthea Limited held its Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2582038494","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582038494?lang=en_us&edition=fundamental","pubTime":"2025-11-11 08:22","pubTimestamp":1762820550,"startTime":"0","endTime":"0","summary":"Opthea Limited held its Annual General Meeting on November 11, 2025. Shareholders approved the re-election of Dr. Jeremy Levin and Ms. Kathy Connell as directors. Proposals for the issue of options to Mr. Lawrence Gozlan and Ms. Kathy Connell under the NED Plan were approved. The issue of options to Dr. Jeremy Levin under the LTIP was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opthea Limited published the original content used to generate this news brief on November 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL2vsmFH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","OPT.AU"],"gpt_icon":0},{"id":"2579467414","title":"Opthea Ltd:  Positioned to Progress and Finalise Its Strategic Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2579467414","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579467414?lang=en_us&edition=fundamental","pubTime":"2025-10-31 21:32","pubTimestamp":1761917560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nFWN3WC33F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","OPT.AU","BK7508"],"gpt_icon":0},{"id":"2579486518","title":"Opthea Continues to Establish Capital Position to Evaluate Strategic Options in the September Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2579486518","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579486518?lang=en_us&edition=fundamental","pubTime":"2025-10-31 09:36","pubTimestamp":1761874603,"startTime":"0","endTime":"0","summary":"Opthea  said it continued to establish a clearer capital position in the September quarter to evaluate its strategic options by simplifying its operations and resolving key financial matters, according to a Friday Australian bourse filing.It noted that its quarterly research and development expenditure fell 80% quarter-over-quarter to $8.3 million, and personnel costs fell 94% to $800,000. It is reviewing all internal assets, intellectual-property holdings, and potential partnerships to create shareholder value.It completed binding settlement and release agreements with investors under the development funding agreement to terminate earlier financing arrangements.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OPT","BK7508","BK7067","OPT.AU"],"gpt_icon":0},{"id":"2579514675","title":"Opthea Ltd: Co Announces Intention to Delist From Nasdaq While Remaining Listed on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2579514675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579514675?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:11","pubTimestamp":1761826280,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB2K1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","OPT.AU"],"gpt_icon":0},{"id":"2579146754","title":"Opthea Streamlines Global Operations and Focuses on Australian Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2579146754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579146754?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:11","pubTimestamp":1761826280,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB2K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OPT.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2579315703","title":"Opthea to Voluntarily Delist American Depositary Shares From Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2579315703","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579315703?lang=en_us&edition=fundamental","pubTime":"2025-10-30 10:03","pubTimestamp":1761789819,"startTime":"0","endTime":"0","summary":"Opthea  notified Nasdaq that it plans to voluntarily delist its American depositary shares representing its ordinary shares, according to a Thursday Australian bourse filing.Opthea no longer has an audit committee that meets Nasdaq's audit committee composition requirements. Concentrating trading on the Australian bourse will simplify governance, reduce expenditure, and align its structure with its operational and strategic priorities, per the firm.It expects to file a Form 25 with the US Securities and Exchange Commission to effect the delisting on or about Nov. 10. Opthea anticipates that the last day of trading of its American depositary shares on Nasdaq will be on or about Nov. 19.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USJW.SI","BK4117","NQmain","BK7067","SQQQ","XAO.AU","BK4139","QLD","OPT","BK7508","TQQQ",".IXIC","MNQmain","XJO.AU","TSYW.SI","BK4107","PSQ","QID","NVIW.SI","XKO.AU","AFG","OPT.AU","USAW.SI"],"gpt_icon":1},{"id":"2579813029","title":"Opthea Ltd-Opthea Announces Intention to Delist From Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2579813029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579813029?lang=en_us&edition=fundamental","pubTime":"2025-10-30 06:31","pubTimestamp":1761777070,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUE6BRF24:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","OPT.AU","BK7067"],"gpt_icon":0},{"id":"2579130260","title":"Opthea Ltd - Expects to File a Form 25 With U.S. Securities and Exchange Commission (SEC) to Effect Delisting on or About November 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579130260","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579130260?lang=en_us&edition=fundamental","pubTime":"2025-10-30 06:31","pubTimestamp":1761777070,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUE6BRF24:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OPT.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2578664193","title":"Opthea Appoints Hamish George as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2578664193","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578664193?lang=en_us&edition=fundamental","pubTime":"2025-10-27 09:38","pubTimestamp":1761529090,"startTime":"0","endTime":"0","summary":"Opthea (ASX:OPT) appointed Hamish George as chief financial officer, effective Monday, according to a same-day Australian bourse filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","OPT.AU","BK4141","XKO.AU","XAO.AU","BK4139","BK7067","OPT","XJO.AU","MMAT"],"gpt_icon":0},{"id":"2578649386","title":"BRIEF-Opthea Says Hamish George Assumes Role Of CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2578649386","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578649386?lang=en_us&edition=fundamental","pubTime":"2025-10-27 09:31","pubTimestamp":1761528678,"startTime":"0","endTime":"0","summary":"BRIEF-Opthea Says Hamish George Assumes Role Of CFO Oct 27 (Reuters) - Opthea Ltd OPT.AX:APPOINTMENT OF COMPANY SECRETARY AND CFOHAMISH GEORGE ASSUMES ROLE OF CFO AT OPTHEAFurther company coverage: OPT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUEVRZ1L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","OPT.AU","BK7508"],"gpt_icon":0},{"id":"2578663659","title":"Opthea Ltd-Appointment of Company Secretary and CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2578663659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578663659?lang=en_us&edition=fundamental","pubTime":"2025-10-27 06:48","pubTimestamp":1761518903,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251026:nTUEVRZ1L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OPT.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2574124091","title":"Opthea Limited announces date for annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2574124091","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574124091?lang=en_us&edition=fundamental","pubTime":"2025-10-10 18:03","pubTimestamp":1760090626,"startTime":"0","endTime":"0","summary":"Opthea Limited will hold its annual general meeting virtually on November 11, 2025. Shareholders will vote on the re-election of Dr. Jeremy Levin and Ms. Kathy Connell as directors, the adoption of the remuneration report, the issue of options to Mr. Lawrence Gozlan under the Non-Executive Directors Share and Option Plan, the issue of options to Ms. Kathy Connell under the same plan, and the issue of options to Dr. Jeremy Levin under the Long-Term Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opthea Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 10, 2025,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL3BkyTK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OPT.AU","BK7067"],"gpt_icon":0},{"id":"2573675228","title":"Opthea Ltd: Receives a$10.8 Million R&D Tax Incentive From the Australian Taxation Office - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2573675228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573675228?lang=en_us&edition=fundamental","pubTime":"2025-10-06 18:15","pubTimestamp":1759745725,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","OPT.AU"],"gpt_icon":0},{"id":"2573675674","title":"Opthea Limited Secures A$10.8 Million Australian R&D Tax Incentive to Advance Sozinibercept Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2573675674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573675674?lang=en_us&edition=fundamental","pubTime":"2025-10-06 18:03","pubTimestamp":1759744987,"startTime":"0","endTime":"0","summary":"Opthea Limited  has announced the receipt of an A$10.8 million  research and development (R&D) tax incentive from the Australian Taxation Office. The incentive, awarded under the Australian Federal Government's R&D Tax Incentive program, supports eligible R&D expenditure for the 2024/2025 financial year, including both Australian and overseas costs related to the development of Opthea's lead candidate, sozinibercept. The funding is exclusive to Opthea Limited and is designed to encourage innovation and advance the company's clinical pipeline. Opthea's Executive Chairman, Jeremy Levin, highlighted the importance of the program in supporting the company's strategic initiatives and reaffirmed a commitment to fiscal discipline while advancing therapeutic development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL2yZcYK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","OPT.AU"],"gpt_icon":0},{"id":"2567130271","title":"Opthea Limited Reports Decline in Revenue to $25K for Fiscal Year Ending June 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2567130271","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567130271?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:50","pubTimestamp":1757933447,"startTime":"0","endTime":"0","summary":"Opthea Limited has released its annual report for the fiscal year ending June 30, 2025. The company reported a revenue of $25,000, a significant decline from the $125,000 reported in 2024 and $108,000 in 2023. Other income for 2025 was reported at $121,000, compared to $137,000 in 2024, and $277,000 in 2023. The company has not generated revenue from sales of approved products to date, with current revenues derived from sales-based royalties related to out-licensing of intellectual property assets not central to its core business. These revenues are expected to remain nominal in future periods. Opthea is focusing on the reformulation of its drug candidates targeting VEGF-C and VEGF-D and has indicated plans to apply for the R&D tax incentive in Australia related to clinical trials for future product candidates. However, the company has stated that there is no assurance that these costs will be eligible for the tax incentive from the Australian Taxation Office. The company is facing unc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL21qXT1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPT.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}